As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

PBMs demand discounts and rebates from drugmakers, which leads the manufacturers to charge higher list ... Cuban Cost Plus Drugs in 2022 to upend the byzantine $500 billion U.S. drug market ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...

The Penn Medicine partnership with Mark Cuban's Cost Plus Drug Co. is designed to cut the health system's drug costs and improve access to prescription medicines. Penn Medicine has entered into a ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are taking ...

More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...

Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a provision in the 2022 Inflation Reduction Act which takes effect this year.

The reality is that there's a long list of middlemen that obfuscate ... "It's very, very simple. If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs ...

The U.S. continues to charge significantly higher prices for prescription drugs compared to similarly wealthy countries.